Other Species / Isoforms
  ZNF830 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
A5
___MASSASARtPAG
0 1
ZNF830 (human) ___MASSASARtPAG A5
ZNF830 (mouse) ___MASStsTRTPAG T5-p
ZNF830 (rat) ___MASSTSARTPAG T5
S6
__MASSASARtPAGK
0 1
ZNF830 (human) __MASSASARtPAGK S6
ZNF830 (mouse) __MASStsTRTPAGK S6-p
ZNF830 (rat) __MASSTSARTPAGK S6
T9-p
ASSASARtPAGKRVI
0 2
ZNF830 (human) ASSASARtPAGKRVI T9-p
ZNF830 (mouse) ASStsTRTPAGKRVV T9
ZNF830 (rat) ASSTSARTPAGKRVV T9
S40-p
TSRKRIEsPFAKYNR
0 5
ZNF830 (human) TSRKRIEsPFAKYNR S40-p
ZNF830 (mouse) TNRKRIEsPFAKYNR S40-p
ZNF830 (rat) TNRKRIESPFAKYNR S40
T58-p
LSCALCNtPVKSELL
0 6
ZNF830 (human) LSCALCNtPVKSELL T58-p
ZNF830 (mouse) LSCALCNtPVKSELL T58-p
ZNF830 (rat) LSCALCNTPVKSELL T58
S89-p
LKGAKEAsQGSsASS
0 5
ZNF830 (human) LKGAKEAsQGSsASS S89-p
ZNF830 (mouse) LKGAKGATQGPSTGT T89
ZNF830 (rat) LKGAKGATQGPSAGT T89
S93-p
KEAsQGSsASSAPHs
0 1
ZNF830 (human) KEAsQGSsASSAPHs S93-p
ZNF830 (mouse) KGATQGPSTGTVPQA S93
ZNF830 (rat) KGATQGPSAGTAPQP S93
S100-p
sASSAPHsVKRKAPD
0 2
ZNF830 (human) sASSAPHsVKRKAPD S100-p
ZNF830 (mouse) STGTVPQATKRRAtD A100
ZNF830 (rat) SAGTAPQPTKRKTTD P100
P106
HsVKRKAPDADDQDV
0 2
ZNF830 (human) HsVKRKAPDADDQDV P106
ZNF830 (mouse) QATKRRAtDVESQDA T106-p
ZNF830 (rat) QPTKRKTTDVESQDA T106
T119-p
DVKRAKAtLVPQVQP
0 1
ZNF830 (human) DVKRAKAtLVPQVQP T119-p
ZNF830 (mouse) DAKKAKASAGPQVQP S119
ZNF830 (rat) DAKKAKASVDQVQPS S119
K137-ac
AWTTNFDkIGKEFIR
0 2
ZNF830 (human) AWTTNFDkIGKEFIR K137-ac
ZNF830 (mouse) ASSANLDAARAAPSK A137
ZNF830 (rat) ASSANFEkSGKEATR K136-ac
T146-p
GKEFIRAtPSkPSGL
0 1
ZNF830 (human) GKEFIRAtPSkPSGL T146-p
ZNF830 (mouse) NLDAARAAPSKPGLG A141
ZNF830 (rat) GKEATRVASSkTGLG A145
K149-ac
FIRAtPSkPSGLSLL
0 2
ZNF830 (human) FIRAtPSkPSGLSLL K149-ac
ZNF830 (mouse) AARAAPSKPGLGLLP K144
ZNF830 (rat) ATRVASSkTGLGLLP K148-ac
Y159-p
GLSLLPDyEDEEEEE
0 1
ZNF830 (human) GLSLLPDyEDEEEEE Y159-p
ZNF830 (mouse) GLGLLPDYDDEEEEE Y153
ZNF830 (rat) GLGLLPDYEEEEEEE Y157
S181-p
ERKRGDAsKPLSDAQ
0 1
ZNF830 (human) ERKRGDAsKPLSDAQ S181-p
ZNF830 (mouse) GEERRDSSKHLPDAQ S172
ZNF830 (rat) GEERRDSSKHLPDAQ S179
S193
DAQGKEHSVSsSREV
0 3
ZNF830 (human) DAQGKEHSVSsSREV S193
ZNF830 (mouse) DAQGKEHsLAsPRET S184-p
ZNF830 (rat) DAQGREHSLAsPRET S191
S196-p
GKEHSVSsSREVTSS
0 12
ZNF830 (human) GKEHSVSsSREVTSS S196-p
ZNF830 (mouse) GKEHsLAsPRETTsN S187-p
ZNF830 (rat) GREHSLAsPRETTSN S194-p
S202
SsSREVTSSVLPNDF
0 1
ZNF830 (human) SsSREVTSSVLPNDF S202
ZNF830 (mouse) AsPRETTsNVLPNDP S193-p
ZNF830 (rat) AsPRETTSNVLPNDP S200
S225-p
PIIPHSGsIEKAEIH
Upstream
0 5
Treatment
  • nocodazole
ZNF830 (human) PIIPHSGsIEKAEIH S225-p
ZNF830 (mouse) PLVPHSGsIEKAEIH S216-p
ZNF830 (rat) PLVPHSGSIEkAEIH S223
K228
PHSGsIEKAEIHEKV
0 1
ZNF830 (human) PHSGsIEKAEIHEKV K228
ZNF830 (mouse) PHSGsIEKAEIHEKV K219
ZNF830 (rat) PHSGSIEkAEIHEkV K226-ac
K234
EKAEIHEKVVERREN
0 1
ZNF830 (human) EKAEIHEKVVERREN K234
ZNF830 (mouse) EKAEIHEKVVERREN K225
ZNF830 (rat) EkAEIHEkVVERREN K232-ac
K267-ac
VRKVDAPkDQMDKEW
0 1
ZNF830 (human) VRKVDAPkDQMDKEW K267-ac
ZNF830 (mouse) VRKVDAPKDQMDKEW K258
ZNF830 (rat) VRKVDAPKDQMDKEW K265
K339
LKEILTIKELQKKEE
0 1
ZNF830 (human) LKEILTIKELQKKEE K339
ZNF830 (mouse) LKEVLTIKELQKKEE K330
ZNF830 (rat) LKEVLTIkELQKKEE K337-ac
S351-p
KEEENADsDDEGELQ
Upstream
0 67
Treatment
  • anti-CD3
  • metastatic potential
ZNF830 (human) KEEENADsDDEGELQ S351-p
ZNF830 (mouse) KEEENVDsDDEGELQ S342-p
ZNF830 (rat) KEEENVDsDDEGELQ S349-p
S362-p
GELQDLLsQDWRVKG
0 4
ZNF830 (human) GELQDLLsQDWRVKG S362-p
ZNF830 (mouse) GELQDLLSQDWRVKG S353
ZNF830 (rat) GELQDLLSQDWRVKG S360